Next Big Step: SK Bioscience Gears Up For Endemic COVID, Next Pandemic
Aggressive M&A Part Of Growth Strategy
With its COVID-19 vaccine development project nearing the finish line, SK Bioscience unveils an ambitious growth strategy which includes mergers and acquisitions and diversification into the cell and gene therapy sector.
